CERVical cancer: AdjuvaNt ThErapy and radical Surgery
CERVATES clinical trial
An international randomised trial of radical surgery followed by adjuvant therapy versus no further
treatment in patients with early-stage, intermediate-risk cervical cancer
Trial News
I. CERVANTES study (protocol version v2.0) was authorised through Clinical Trial Information System (CTIS) in Austria, Belgium, Italy, Poland and Spain.
Austria - 5 sites
Belgium - 5 sites
Italy - 1 site
Poland - 5 sites
Spain - 6 sites
II. CERVANTES Portuguese translation under preparation for Brazilian International Review Board (IRB) - registration of 3 sites
III. 52 patients enrolled from 11 recruiting centres in 8 countries - 9 more sites are waiting for their first patient
We got together; ESGO 2026 Copenhagen CERVANTES investigator meeting.
Friday 27.2.2026 18:00-18:30 ESGO meeting room 1
Subscribe for CERVANTES Trial
newsletter*